Open for bids Tender Germany ICB TOT Ref. 152386468

Open House Drug Discount Agreements for the Active Tender - 152386468

Tender notice from Germany, published on 12 Nov 2026.

Executive Summary

Title/Summary: Tender for non-exclusive discount contracts for the drug Nintedanib by AOK Rheinland-Pfalz/Saarland, Germany. Contracts commence on January 1, 2027, and run until December 31, 2028. Interested pharmaceutical companies can submit applications until November 30, 2026.

Scope Of Work: The tender involves entering into non-exclusive discount contracts for the pharmaceutical substance Nintedanib, following specific regulations. The contracts will be established under an open-house model, allowing all interested pharmaceutical companies to participate without a selection process. The contracts have a maximum duration of 24 months, starting from January 1, 2027, with the possibility of joining at the beginning of any month. All contracts will end 24 months after the earliest start date. The procedure excludes certain children's medications as per regulatory guidelines.

Qualification Criterion: Eligibility is restricted to pharmaceutical companies. Interested parties must submit their application documents electronically with a qualified electronic signature or in hard copy, ensuring confidentiality. The application deadline is November 30, 2026. Contracts will not be awarded under public procurement regulations, and transparency in contract awards will be maintained through publication in the EU Official Journal.

Key facts

Summary
Open House Drug Discount Agreements for the Active Ingredient Nintedanib, Atc L01ex09
TOT Ref. No.
152386468
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
12 Nov 2026
Bid deadline
31 Oct 2028
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Open House Drug Discount Agreements for the Active Ingredient Nintedanib, Atc L01ex09 is 31 Oct 2028. Submit before this date to be considered.

This tender has been issued by AOK RHINELAND-PALATINATE/SAARLAND - THE HEALTH INSURANCE FUND in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152386468. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.